EMEA-001739-PIP02-16-M02 - paediatric investigation plan

ketamine (hydrochloride)
sufentanil citrate
PIPHuman

Key facts

Active Substance
  • ketamine (hydrochloride)
  • sufentanil citrate
Therapeutic area
Pain
Decision number
P/0320/2023
PIP number
EMEA-001739-PIP02-16-M02
Pharmaceutical form(s)
Nasal spray (solution)
Condition(s) / indication(s)
Treatment of acute pain
Route(s) of administration
Intranasal use
Contact for public enquiries

Cessatech A/S

E-mail: info@cessatech.com
Tel: +45 93872309  

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page